| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.67B | +13.3% |
| Cost of Revenue | $7.29B | +24.6% |
| Gross Profit | $2.38B | -11.3% |
| R&D Expense | $112.0M | +30.2% |
| SG&A Expense | $824.0M | +30.2% |
| Operating Income | $1.38B | -29.2% |
| Interest Expense | $405.0M | +345.1% |
| Pre-tax Income | $1.42B | -36.8% |
| Income Tax | -$489.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.51B | +181.3% |
| Accounts Receivable | $1.38B | +18.8% |
| Inventory | $2.81B | +84.3% |
| Current Assets | $6.61B | +73.7% |
| Total Assets | $26.27B | +119.4% |
| Current Liabilities | $4.07B | +62.4% |
| Long-term Debt | $13.95B | +274.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.82B | +3.5% |
| Capital Expenditures | $543.0M | +16.3% |
| Investing Cash Flow | -$11.14B | -895.6% |
| Financing Cash Flow | $10.29B | +1087.5% |
| Free Cash Flow | $1.28B | -1.1% |
| -248.2% |
| Net Income | $1.89B | +0.2% |
| EPS (Basic) | $17.48 | +2.9% |
| EPS (Diluted) | $17.34 | +2.8% |
| Stockholders' Equity |
| $5.64B |
| +34.6% |